CVS To Pay $5M To End FTC's Deceptive Drug Price Claims
CVS Caremark Corp. on Thursday agreed to pay $5 million to settle Federal Trade Commission allegations that it posted inaccurate prices for certain Medicare prescription drugs that caused some patients to...To view the full article, register now.
Already a subscriber? Click here to view full article